Target intelligence / Profile preview

Pseudogene similar to part of Anoctamin 10 (ENSG00000256350)

Target
ENSG00000256350
Molecular classification
Pseudogene
01

Overview

ENSG00000256350 is a human pseudogene annotated as 'pseudogene similar to part of anoctamin 10.' Pseudogenes typically contain high sequence homology to their parent genes—in this case, Anoctamin 10 (ANO10), a calcium-activated chloride channel implicated in spinocerebellar ataxia[1][5]. Pseudogenes may arise by duplication or retrotransposition but suffer mutations or loss of regulatory sequences; thus, they may lack the ability to express functional proteins[4][6]. While some pseudogenes have been assigned regulatory roles or suggested as disease biomarkers, most remain nonfunctional and are not considered therapeutic targets[2]. No structure, function, or disease relevance has been directly assigned to ENSG00000256350, and it is not recognized as a canonical molecular target for therapy or research. Key points: - ENSG00000256350 is a pseudogene, not a protein-coding gene, receptor, ion channel, or enzyme. - No functional, disease, or drug-related information associated with it. - Not suitable as a canonical or therapeutic target; therefore, entries like drugs, mechanism, and biomarkers are null.

02

Biological functions

Most pseudogenes do not encode a functional protein. Some pseudogenes can regulate gene expression, impact genetic networks, or very rarely encode peptides, but there is no evidence ENSG00000256350 plays any such role specifically.
03

Disease associations

Although some pseudogenes serve as biomarkers or have regulatory roles in cancer or other diseases, there is no evidence that ENSG00000256350 is involved in disease, nor directly implicated as a causal gene for any condition.

Beyond the preview

Go deeper on Pseudogene similar to part of Anoctamin 10 (ENSG00000256350).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudogene similar to part of Anoctamin 10 (ENSG00000256350).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call